The Pharmaceutical Journal
Vol 270 No 7232 p81
18 January 2003

This page
Reprint
Photocopy

PDF* 80K

  Period-of-treatment fee
  Community pharmacy
  Locum pharmacy
  Hospital pharmacy
  PILs
  ReQuip
  The Profession
  Women's health
  CPD
  Scottish Executive
  The Society
  Registration exam
  Supervision
  The Register
  Christmas miscellany

Letters to the Editor

ReQuip

Potential for error when switching packs

From Mr D. J. Hamblin, MRPharmS

I write to highlight potential for error with the ReQuip starter pack. This new 105-tablet pack replaces the 210-tablet starter pack which consisted of 210 x 0.25mg tablets (PJ, 21/28 December 2002, p883). The new pack has three strengths of ropinirole in it: 0.25mg, 0.5mg and 1mg tablets.

It appears that wholesalers are simply replacing the old with the new on the order code and this can cause difficulties if only the 0.25mg tablets are required.

Although we have had a mailing from GlaxoSmithKline to point this out, there are, nevertheless, inherent dangers in switching these products.

David Hamblin
Norwich

Send your letter to The Editor

Previous Topic (PILs)
Next Topic (The Profession)